1. Home
  2. QTRX vs DMB Comparison

QTRX vs DMB Comparison

Compare QTRX & DMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • DMB
  • Stock Information
  • Founded
  • QTRX 2007
  • DMB 2013
  • Country
  • QTRX United States
  • DMB United States
  • Employees
  • QTRX N/A
  • DMB N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • DMB Trusts Except Educational Religious and Charitable
  • Sector
  • QTRX Industrials
  • DMB Finance
  • Exchange
  • QTRX Nasdaq
  • DMB Nasdaq
  • Market Cap
  • QTRX 241.2M
  • DMB 196.9M
  • IPO Year
  • QTRX 2017
  • DMB N/A
  • Fundamental
  • Price
  • QTRX $5.95
  • DMB $10.71
  • Analyst Decision
  • QTRX Hold
  • DMB
  • Analyst Count
  • QTRX 4
  • DMB 0
  • Target Price
  • QTRX $11.75
  • DMB N/A
  • AVG Volume (30 Days)
  • QTRX 425.0K
  • DMB 76.6K
  • Earning Date
  • QTRX 11-11-2025
  • DMB 01-01-0001
  • Dividend Yield
  • QTRX N/A
  • DMB 4.17%
  • EPS Growth
  • QTRX N/A
  • DMB N/A
  • EPS
  • QTRX N/A
  • DMB N/A
  • Revenue
  • QTRX $125,784,000.00
  • DMB N/A
  • Revenue This Year
  • QTRX N/A
  • DMB N/A
  • Revenue Next Year
  • QTRX $37.89
  • DMB N/A
  • P/E Ratio
  • QTRX N/A
  • DMB N/A
  • Revenue Growth
  • QTRX N/A
  • DMB N/A
  • 52 Week Low
  • QTRX $4.05
  • DMB $8.94
  • 52 Week High
  • QTRX $15.67
  • DMB $11.79
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 60.51
  • DMB 71.17
  • Support Level
  • QTRX $5.60
  • DMB $10.53
  • Resistance Level
  • QTRX $6.20
  • DMB $10.65
  • Average True Range (ATR)
  • QTRX 0.33
  • DMB 0.07
  • MACD
  • QTRX 0.01
  • DMB -0.01
  • Stochastic Oscillator
  • QTRX 73.44
  • DMB 94.74

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About DMB BNY Mellon Municipal Bond Infrastructure Fund Inc.

BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a diversified closed-end management investment company. The fund's investment objective is to provide as high a current income exempt from regular federal income tax as is consistent with the preservation of capital. It invests in transportation, energy and utilities, social infrastructure, and water and environmental sectors.

Share on Social Networks: